102
Views
45
CrossRef citations to date
0
Altmetric
Original Research

Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles

, , , , &
Pages 3939-3950 | Published online: 12 Aug 2016

References

  • PaefgenVDoleschelDKiesslingFEvolution of contrast agents for ultrasound imaging and ultrasound-mediated drug deliveryFront Pharmacol2015619726441654
  • PuCChangSSunJUltrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles for the treatment of intraperitoneal ovarian cancer xenograftsMol Pharm2014111495824237050
  • FreiseACWuAMIn vivo imaging with antibodies and engineered fragmentsMol Immunol2015672 Pt A14215225934435
  • HoytKWarramJMWangDRatnayakaSTraylorAAgarwalAMolecular Ultrasound Imaging of Tissue Inflammation Using an Animal Model of Acute Kidney InjuryMol Imaging Biol201517678679225905474
  • AlonsoAArtemisDHennericiMGMolecular imaging of carotid plaque vulnerabilityCerebrovasc Dis201539151225547782
  • AndersonCRHuXZhangHUltrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agentInvest Radiol201146421522421343825
  • DixonAJKilroyJPDhanaliwalaAHMicrobubble-mediated intravascular ultrasound imaging and drug deliveryIEEE Trans Ultrason Ferroelectr Freq Control20156291674168526415129
  • WangDYangKGaoYHTanKBLiuZPreparation and characterization of a nanoscale ultrasound contrast agentClin Imaging201034428829220630341
  • XingZWangJKeHThe fabrication of novel nanobubble ultrasound contrast agent for potential tumor imagingNanotechnology2010211414560720220227
  • CaiWBYangHLZhangJThe Optimized Fabrication of Nanobubbles as Ultrasound Contrast Agents for Tumor ImagingSci Rep201551372526333917
  • RistauBTO’KeefeDSBacichDJThe prostate-specific membrane antigen: lessons and current clinical implications from 20 years of researchUrol Oncol201432327227924321253
  • WangLLiLGuoYConstruction and in vitro/in vivo targeting of PSMA-targeted nanoscale microbubbles in prostate cancerProstate201373111147115823532872
  • FanXWangLGuoYUltrasonic Nanobubbles Carrying Anti-PSMA Nanobody: Construction and Application in Prostate Cancer-Targeted ImagingPlos One2015106e012741926111008
  • PaiSSEllingtonADUsing RNA aptamers and the proximity ligation assay for the detection of cell surface antigensMethods Mol Biol200950438539819159107
  • McNamaraJO2ndAndrechekERWangYCell type-specific delivery of siRNAs with aptamer-siRNA chimerasNat Biotechnol20062481005101516823371
  • BaekSELeeKHParkYSRNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivoJ Control Release201419623424225450401
  • ChuTCShiehFLaveryLALabeling tumor cells with fluorescent nanocrystal-aptamer bioconjugatesBiosens Bioelectron200621101859186616495043
  • MathewAMaekawaTSakthikumarDAptamers in targeted nano-therapyCurr Top Med Chem201515121102111425866269
  • DoughertyCACaiWHongHApplications of aptamers in targeted imaging: state of the artCurr Top Med Chem201515121138115225866268
  • AlibolandiMRamezaniMAbnousKIn vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancerJ Control Release20152098810025912964
  • LeeIHAnSYuMKKwonHKImSHJonSTargeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugatesJ Control Release2011155343544121641946
  • LupoldSEHickeBJLinYCoffeyDSIdentification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigenCancer Res200262144029403312124337
  • DassieJPHernandezLIThomasGSTargeted inhibition of prostate cancer metastases with an RNA aptamer to prostate-specific membrane antigenMol Ther201422111910192224954476
  • RockeyWMHernandezFJHuangSYRational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modelingNucleic Acid Ther201121529931422004414
  • WuXDingBGaoJSecond-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapyInt J Nanomedicine201161747175621980237
  • KiesslingFFokongSBzylJLederleWPalmowskiMLammersTRecent advances in molecular, multimodal and theranostic ultrasound imagingAdv Drug Deliv Rev201472152724316070
  • NiuCCWangZGZuoGQPoly(Lactide-co-glycolide) ultrasonographic microbubbles carrying Sudan black for preoperative and intraoperative localization of lymph nodesClin Breast Cancer201212319920622402214
  • SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin201565152925559415
  • WibmerAGBurgerIASalaEHricakHWeberWAVargasHAMolecular Imaging of Prostate CancerRadiographics201636114215926587888
  • GupteAAHamiltonDJMolecular Imaging and Precision MedicineCardiology2016133317818026606040
  • KangSTYehCKUltrasound microbubble contrast agents for diagnostic and therapeutic applications: current status and future designChang Gung Med J201235212513922537927
  • ShiCZhuYXieZVisualizing human prostate cancer cells in mouse skeleton using bioconjugated near-infrared fluorescent quantum dotsUrology200974244645119428067
  • PurohitRSShinoharaKMengMVCarrollPRImaging clinically localized prostate cancerUrol Clin North Am200330227929312735504
  • Abou-ElkacemLBachawalSVWillmannJKUltrasound molecular imaging: Moving toward clinical translationEur J Radiol20158491685169325851932
  • PochonSTardyIBussatPBR55: a lipopeptide-based VEGFR2–targeted ultrasound contrast agent for molecular imaging of angiogenesisInvest Radiol2010452899520027118
  • WangCHKangSTLeeYHLuoYLHuangYFYehCKAptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosisBiomaterials20123361939194722142768
  • YangHCaiWXuLNanobubble-Affibody: Novel ultrasound contrast agents for targeted molecular ultrasound imaging of tumorBiomaterials20153727928825453958
  • YinTWangPZhengRNanobubbles for enhanced ultrasound imaging of tumorsInt J Nanomedicine2012789590422393289
  • CarsonARMcTiernanCFLaveryLGene therapy of carcinoma using ultrasound-targeted microbubble destructionUltrasound Med Biol201137339340221256666
  • KohlerNSunCWangJZhangMMethotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cellsLangmuir200521198858886416142971
  • DassieJPLiuXYThomasGSSystemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumorsNat Biotechnol200927983984919701187
  • XuWSiddiquiIANihalMAptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancerBiomaterials201334215244525323582862
  • DharSKolishettiNLippardSJFarokhzadOCTargeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivoProc Natl Acad Sci U S A201110851850185521233423
  • KimEJungYChoiHProstate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplexBiomaterials201031164592459920206379